Mimetogen Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
6
Mimetogen Pharmaceuticals General Information
Description
Operator of a clinical-stage biotechnology company intended to focus on the development of peptidomimetics. The company's peptidomimetics focuses on treating dry eye, glaucoma, keratoconus, and retinitis pigmentosa, enabling healthcare providers to treat ophthalmic diseases.
Contact Information
Website
www.mimetogen.comCorporate Office
- 1000 de La Gauchetière Street West
- Suite 2100
- Montreal, Quebec H3B 4W5
- Canada
Corporate Office
- 1000 de La Gauchetière Street West
- Suite 2100
- Montreal, Quebec H3B 4W5
- Canada
Mimetogen Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Accelerator/Incubator | 01-Jan-2018 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | 18-Jul-2013 | Completed | Clinical Trials - Phase 3 | |||
| 4. Later Stage VC (Series B) | 25-Feb-2011 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 07-Oct-2009 | Completed | Startup | |||
| 2. Seed Round | 31-Oct-2005 | $848K | $848K | Completed | Startup | |
| 1. University Spin-Out | 01-Sep-2005 | Completed | Startup |
Mimetogen Pharmaceuticals Comparisons
Industry
Financing
Details
Mimetogen Pharmaceuticals Competitors (18)
One of Mimetogen Pharmaceuticals’s 18 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Cardurion | Venture Capital-Backed | Burlington, MA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Gilead Sciences | Formerly VC-backed | Foster City, CA | ||||
| Ability Pharma | Private Equity-Backed | Barcelona, Spain |
Mimetogen Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Mimetogen Pharmaceuticals Patents
Mimetogen Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190194251-A1 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Active | 09-Jul-2015 | ||
| US-11078234-B2 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Active | 09-Jul-2015 | ||
| US-10125165-B2 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Active | 09-Jul-2015 | ||
| EP-3319978-A1 | Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts | Active | 09-Jul-2015 | ||
| JP-2018528928-A | Liquid phase synthesis and crystallization of β-turn peptidomimetic cyclic salts | Active | 09-Jul-2015 | C07K1/02 |
Mimetogen Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mimetogen Pharmaceuticals Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| McGill Dobson Centre for Entrepreneurship | Accelerator/Incubator | Minority | ||
| Schooner Capital | Growth/Expansion | Minority | ||
| Medwell Capital | Investment Bank | Minority | ||
| MSBi Valorisation | Venture Capital | Minority | ||
| Inovia Capital | Venture Capital | Minority |
Mimetogen Pharmaceuticals FAQs
-
When was Mimetogen Pharmaceuticals founded?
Mimetogen Pharmaceuticals was founded in 2005.
-
Where is Mimetogen Pharmaceuticals headquartered?
Mimetogen Pharmaceuticals is headquartered in Montreal, Canada.
-
What is the size of Mimetogen Pharmaceuticals?
Mimetogen Pharmaceuticals has 3 total employees.
-
What industry is Mimetogen Pharmaceuticals in?
Mimetogen Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Mimetogen Pharmaceuticals a private or public company?
Mimetogen Pharmaceuticals is a Private company.
-
What is Mimetogen Pharmaceuticals’s current revenue?
The current revenue for Mimetogen Pharmaceuticals is .
-
How much funding has Mimetogen Pharmaceuticals raised over time?
Mimetogen Pharmaceuticals has raised $3.65M.
-
Who are Mimetogen Pharmaceuticals’s investors?
McGill Dobson Centre for Entrepreneurship, Schooner Capital, Medwell Capital, MSBi Valorisation, and Inovia Capital are 5 of 6 investors who have invested in Mimetogen Pharmaceuticals.
-
Who are Mimetogen Pharmaceuticals’s competitors?
Genentech, Cardurion, Merck & Co., Gilead Sciences, and Ability Pharma are some of the 18 competitors of Mimetogen Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
